In a medical first for the UK, eight babies have been born using a pioneering IVF technique that combines the DNA of three people to prevent inherited mitochondrial diseases-devastating genetic conditions that can cause severe disability or early death.
This revolutionary approach, known as mitochondrial donation, offers hope to families affected by genetic disorders passed down through the maternal line. It represents a breakthrough in the field of assisted reproductive technology, especially for those at risk of transmitting incurable mitochondrial disease to their children
What Is Three-Person IVF and How Does It Work?
Three-person IVF involves combining genetic material from three individuals: the biological mother and father, and a female mitochondrial donor. The technique replaces faulty mitochondria in the mother’s egg with healthy mitochondria from a donor egg, significantly reducing the risk of inherited mitochondrial conditions.
Here’s how it works:
- Both the mother’s and the donor’s eggs are fertilized in a lab with the father’s sperm.
- Scientists then remove the nuclear DNA (which contains most of the genetic information like eye color and height) from both embryos.
- The nuclear DNA from the parents is inserted into the donor embryo, which contains healthy mitochondria.
- The resulting embryo, now made from 99.9% of the parents’ DNA and 0.1% from the donor, is implanted into the mother’s uterus.
This means the child is biologically related to the parents but carries a small, healthy portion of mitochondrial DNA from the donor woman. Girls born through this process will also pass this healthy DNA on to future generations.
Why Mitochondrial DNA Matters
Mitochondria are tiny powerhouses within our cells that generate energy for vital body functions. When mitochondria are faulty, the body struggles to produce enough energy, which can lead to serious complications like:
- Seizures
- Heart problems
- Muscle weakness
- Brain damage
- Blindness
- Organ failure
These conditions are passed down maternally and affect around 1 in 5,000 births. Some babies live only a few days, while others face lifelong disability. For families with a history of mitochondrial disease, the risk of recurrence can be overwhelming
Real Lives Changed by Science
Although the families involved have chosen to remain anonymous, they’ve shared heartfelt statements through the Newcastle Fertility Centre, where the procedures were carried out.
“After years of uncertainty, this treatment gave us hope – and then it gave us our baby,” shared one grateful mother.
“Thanks to this incredible advancement and the support we received, our little family is complete,” said another. “The emotional burden of mitochondrial disease has been lifted.”
These eight babies-four girls and four boys, including a set of twins-are all developing normally and free of the mitochondrial diseases that plagued their families.
A Decade in the Making
The science behind mitochondrial replacement therapy was developed over ten years ago at Newcastle University and Newcastle Hospitals NHS Foundation Trust. In 2015, the UK made history by becoming the first country to legalize the use of this technique in fertility treatment after an extensive parliamentary vote and public consultation.
The NHS Highly Specialised Service for Rare Mitochondrial Disorders began offering this treatment in 2017, and the first babies have now been born.
According to Professor Bobby McFarland, director of the service, “To see the relief and joy in the faces of the parents of these babies after such a long wait and fear of consequences, it’s brilliant to be able to see these babies alive, thriving, and developing normally.”
Monitoring Health and Safety
All children born through this method are closely monitored. So far, the health outcomes have been overwhelmingly positive:
- One child had epilepsy, which resolved on its own.
- Another child has a manageable heart rhythm issue.
Crucially, no cases of mitochondrial disease have emerged. In most babies, the diseased mitochondria were undetectable; in a few, they made up less than 20% of the mitochondrial DNA-well below the threshold that typically causes illness.
Hope for Future Generations
Families like the Kitto family, affected by mitochondrial disease, see this as a lifeline. Kat Kitto’s youngest daughter Poppy, 14, lives with the condition, while her older daughter Lily fears passing it on.
“It’s the future generations who can now look forward to a normal life,” Lily said.
The success of these first births opens the door for more families to access mitochondrial donation IVF, with around 20 to 30 cases expected annually in the UK.
A Word of Caution – and Optimism
While this breakthrough is monumental, experts urge continued research to refine the technique and understand any long-term risks. But for many, this marks the beginning of a new era in reproductive medicine.
Professor Mary Herbert of Newcastle and Monash University noted:
“These findings give grounds for optimism. However, research to better understand the limitations of mitochondrial donation technologies will be essential to further improve treatment outcomes.”
Choosing the Right IVF Clinic Matters
If you’re considering fertility treatment and are at risk of passing on genetic conditions, it’s crucial to:
- Ask your clinic if they’re licensed to offer mitochondrial donation IVF
- Find out which regulatory body oversees their practice, such as the HFEA (Human Fertilisation and Embryology Authority) in the UK
- Explore your eligibility for advanced IVF procedures if you have a family history of mitochondrial or other inherited diseases
A Brighter Future Through Genetic Innovation
Thanks to cutting-edge science and compassionate regulation, babies are now being born healthy-free from diseases that once seemed inevitable. Three-person IVF may still be in its early stages, but it represents a giant leap toward ending the cycle of inherited mitochondrial disease and giving future generations a chance at a full, healthy life.
